Stocktoria
Bio Green Med Solution, Inc. BGMS
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 1996-01-01
Bio Green Med Solution, Inc. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating margin | -1128.1% | -27916.3% | -6060.2% | — | — |
| Net margin | -401.3% | -26074.4% | -5370.2% | — | — |
| FCF margin | — | — | -3837.6% | — | — |
| Return on assets | -36.6% | -273.9% | -256.2% | -75.6% | -44.3% |
| Return on equity | -43.8% | 515.7% | -3715.8% | -133.0% | -50.1% |
| Current ratio | 4.70 | 0.59 | 0.91 | 3.25 | 7.73 |
| Revenue growth | 1637.2% | -89.8% | — | — | — |
Source: SEC EDGAR filings · CIK 0001130166 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.